Astrazeneca Plc
Mar 06, 2012 at 14:56 | Source: Reuters
Sep 05, 2011 at 15:47 | Source: Reuters
Photos »
/ 
News across the web »
May 18, 2012 at 10:00 | Source: Business Week
May 15, 2012 at 16:00 | Source: Bloomberg
May 15, 2012 at 08:00 | Source: Bloomberg
May 15, 2012 at 08:00 | Source: Business Week
May 09, 2012 at 01:56 | Source: Business Standard
Interact & exchange stock tips & market info »
Related News »
AstraZeneca PLC (AstraZeneca) is a leading pharmaceutical company. The company discovers, develops, produces and markets a broad range of biologics, prescription pharmaceuticals and vaccines for the treatment of diseases such as cancer, cardiovascular ...
May 20, 2012 at 16:31 | Source: Transworld News
AstraZeneca Plc (AZN), the U.K.’s second- biggest drugmaker, shouldn’t get a further reduction for an antitrust fine of 52.5 million euros ($67.5 million), an adviser to the European Union’s highest court said. Jan Mazak, the advocate ...
May 15, 2012 at 10:25 | Source: Bloomberg
AstraZeneca PLC (>> AstraZeneca plc) said Monday it bought 130,000 of its own ordinary shares of AstraZeneca at 2609 pence per share to cancel. -Shares at 0745 GMT up 23 pence, or 1%, at 2655 pence valuing the company at GBP33.6 billion. -By Ed Ballard ...
May 28, 2012 at 08:15 | Source: 4-traders (press release)
New York, May 29th (TradersHuddle.com) - Shares of AstraZeneca PLC (NYSE:AZN) finished near calculated support at $40.76. The London, England based biopharmaceutical company closed at $41.23 leaving shares at a level that will spark interest by traders ...
May 29, 2012 at 12:17 | Source: TradersHuddle.com
AstraZeneca PLC announced that on 24 May 2012, it purchased for cancellation 153,000 ordinary shares of AstraZeneca PLC at a price of 2605 pence per share. Upon the cancellation of these shares, the number of shares in issue will be 1,264,461,837.
May 25, 2012 at 12:50 | Source: cisionwire.com
Financial News Roundup: AstraZeneca, GlaxoSmithKline, Bankia needs a cool 15bn EUR, Interserve contract win. As new drug resistant superbugs such as the "New Delhi" bug have emerged, GlaxoSmithKline and AstraZeneca have teamed up with academics and other ...
May 25, 2012 at 09:23 | Source: Director of Finance online
May 15 (Bloomberg) -- Amylin Pharmaceuticals Inc. has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi, which signed confidentiality agreements on the drugmaker's sale process, said people familiar with the matter. Merck & Co ...
May 15, 2012 at 14:49 | Source: San Francisco Gate
Eli Lilly & Co. (LLY) and AstraZeneca Plc (AZN) won’t have an easier time gaining more of the market for blood thinners dominated by Bristol-Myers Squibb Co. (BMY)’s Plavix after the drug lost U.S. patent protection yesterday. Lilly’s ...
May 18, 2012 at 11:11 | Source: Bloomberg
In the past year, the stock has hit a 52-week low of $40.89 and..... Thursday, May 03, 2012... AstraZeneca Plc (NYSE: AZN) closed Wednesday's trading session at $44.09. In the past year, the stock has hit a 52-week low of $40.89 and 52-week..... Friday ...
May 22, 2012 at 11:42 | Source: Market Intelligence Center
“All you have to do is look at the statistics. The numbers are enormous and growing.” Pfizer Inc. (PFE) (PFE), AstraZeneca Plc (AZN) and Roche Holding AG (ROG) had signed confidentiality agreements on Amylin’s sale process, people familiar ...
May 25, 2012 at 17:58 | Source: Businessweek